Skip to main content
SpringerLink
Log in

Diabetic Retinopathy

  • Chapter
  • First Online:
Optical Coherence Tomography

  • 2651 Accesses

Abstract

Diabetic retinopathy is the most common microvascular complication of diabetes mellitus. Of its varying manifestations, diabetic macular edema (DME) is the most frequent cause of vision loss in these patients. Optical coherence tomography (OCT) allows for the characterization and monitoring of DME, tractional retinal detachment, epiretinal membrane formation, and diabetic papillopathy and serves as an objective measure to which clinical decisions regarding treatment for these conditions can be determined. Illustrative cases will be presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhang X, Saaddine JB, Chou C-F, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010;304(6):649–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ho AC, Scott IU, Kim SJ, et al. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology. 2012;119(10):2179–88.

    Article  PubMed  Google Scholar 

  3. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105(10):1801–15.

    Article  CAS  PubMed  Google Scholar 

  4. Brown DM, Nguyen QD, Marcus DM, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology. 2013;120(10):2013–22.

    Article  PubMed  Google Scholar 

  5. Diabetic Retinopathy Clinical Research Network, Elman MJ, Qin H, et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology. 2012;119(11):2312–8.

    Article  PubMed Central  Google Scholar 

  6. Diabetic Retinopathy Clinical Research Network, Googe J, Brucker AJ, et al. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina Phila Pa. 2011;31(6):1009–27.

    Article  Google Scholar 

  7. Do DV, Nguyen QD, Boyer D, et al. One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology. 2012;119(8):1658–65.

    Article  PubMed  Google Scholar 

  8. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–25.

    Article  PubMed  Google Scholar 

  9. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care. 2010;33(11):2399–405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801.

    Article  PubMed  Google Scholar 

  11. Nguyen QD, Shah SM, Heier JS, et al. Primary end point (six months) results of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology. 2009;116(11):2175–2181.e1.

    Article  PubMed  Google Scholar 

  12. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology. 2010;117(11):2146–51.

    Article  PubMed  Google Scholar 

  13. Regillo CD, Brown GC, Savino PJ, et al. Diabetic papillopathy. Patient characteristics and fundus findings. Arch Ophthalmol. 1995;113(7):889–95.

    Article  CAS  PubMed  Google Scholar 

  14. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology. 2008;115(10):1818–25.

    Article  PubMed  Google Scholar 

  15. Al-Haddad CE, Jurdi FA, Bashshur ZF. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am J Ophthalmol. 2004;137(6):1151–3.

    Article  CAS  PubMed  Google Scholar 

  16. Al-Hinai AS, Al-Abri MS, Al-Hajri RH. Diabetic papillopathy with macular edema treated with intravitreal bevacizumab. Oman J Ophthalmol. 2011;4(3):135–8.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kim M, Lee J-H, Lee S-J. Diabetic papillopathy with macular edema treated with intravitreal ranibizumab. Clin OphthalmolAuckl NZ. 2013;7:2257–60.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Wills Eye Hospital, Philadelphia, PA, USA

    M. Ali Khan MD & Alexander Juhn MD

Authors
  1. M. Ali Khan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander Juhn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Ali Khan MD .

Editor information

Editors and Affiliations

  1. London, United Kingdom

    Aniz Girach

  2. Neuro-Ophthalmology Service, Wills Eye Institute, Philadelphia, Pennsylvania, USA

    Robert C. Sergott

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Khan, M.A., Juhn, A. (2016). Diabetic Retinopathy. In: Girach, A., Sergott, R. (eds) Optical Coherence Tomography. Springer, Cham. https://doi.org/10.1007/978-3-319-24817-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24817-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24815-8

  • Online ISBN: 978-3-319-24817-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation